OKYO Pharma Ltd (OKYO) — Institutional Holders, Q2 2026
19 institutional investment managers reported a OKYO position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $9.7M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
OKYO in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Opaleye ManagementNew · +375,204 sh+$562.8K
- CHOREONew · +33,255 sh+$49.9K
- Quantinno Capital ManagementNew · +33,255 sh+$49.9K
- Stonepine Capital ManagementAdded · +12,996 sh+$19.5K
- RENAISSANCE TECHNOLOGIESNew · +11,200 sh+$16.8K
Biggest sellers
- Maven Securities LTDTrimmed · -366,218 sh-$549.3K
- UBS Group AGTrimmed · -4,751 sh-$7.1K
- BALYASNY ASSET MANAGEMENT L.P.Trimmed · -4,200 sh-$6.3K
- Dauntless Investment GroupSold out · -3,819 sh-$5.7K
OKYO 13F holders ranked 1–19 of 19
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Woodline Partners#1 · 3,652,768 sh | 3,652,768 | $5.5M | 0.02% | 0.0% |
| 2 | Stonepine Capital Management#2 · 862,996 sh | 862,996 | $1.3M | 0.61% | +1.5% |
| 3 | Maven Securities LTD#3 · 809,317 sh | 809,317 | $1.2M | 0.02% | -31.2% |
| 4 | BALYASNY ASSET MANAGEMENT L.P.#4 · 580,596 sh | 580,596 | $870.9K | <0.01% | -0.7% |
| 5 | Opaleye Management#5 · 375,204 sh | 375,204 | $562.8K | 0.05% | New |
| 6 | UBS Group AG#6 · 55,009 sh | 55,009 | $82.5K | 0.00% | -8.0% |
| 7 | XTX Topco Ltd#7 · 37,769 sh | 37,769 | $56.7K | <0.01% | +0.3% |
| 8 | CHOREO#8 · 33,255 sh | 33,255 | $49.9K | <0.01% | New |
| 9 | Quantinno Capital Management#9 · 33,255 sh | 33,255 | $49.9K | <0.01% | New |
| 10 | Cerity Partners#10 · 12,812 sh | 12,812 | $19.2K | 0.00% | 0.0% |
| 11 | GEODE CAPITAL MANAGEMENT#11 · 12,090 sh | 12,090 | $18.1K | 0.00% | 0.0% |
| 12 | RENAISSANCE TECHNOLOGIES#12 · 11,200 sh | 11,200 | $16.8K | 0.00% | New |
| 13 | JANE STREET GROUP#13 · 10,302 sh | 10,302 | $15.5K | 0.00% | New |
| 14 | Steward Partners Investment Advisory#14 · 6,000 sh | 6,000 | $9.0K | 0.00% | New |
| 15 | EFG International AG#15 · 923 sh | 923 | $1.4K | 0.00% | 0.0% |
| 16 | OSAIC#16 · 152 sh | 152 | $228.00 | 0.00% | 0.0% |
| 17 | Continuum Advisory#17 · 50 sh | 50 | $75.00 | 0.00% | New |
| 18 | MORGAN STANLEY#18 · 10 sh | 10 | $15.00 | 0.00% | 0.0% |
| 19 | Caitong International Asset Management , Ltd#19 · 3 sh | 3 | $4.00 | 0.00% | New |
Funds that sold out of OKYO in Q2 2026 (1)
Held OKYO at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Dauntless Investment Group3,819 sh | 3,819 | $6.1K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.